Colorectal Neoplasms: all 5,738 studies
Page 48 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.
- Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer PatientsCompletedNCT01523431Phase 2/3
- Prehabilitation in Liver SurgeryCompletedNCT01523353Phase 1
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
- Colorectal Cancer (CRC) Cetuximab Elderly FrailTerminatedNCT01522612Phase 2
- The Value of Narrow Band Imaging in Stratifying Patients for Endoscopic Resection or SurgeryCompletedNCT01521104
- Comparison of Diagnostic Accuracy for Predicting Histology of Colorectal LesionsCompletedNCT01521091
- Colorectal Cancer Screening With Improved Shared Decision MakingCompletedNCT01519999Not applicable
- Trial Comparing Moviprep and Phosphoral as Bowel Prep Before ColonoscopyCompletedNCT01519609Not applicable
- Improving Fecal Occult Blood Test Completion Rates Among VeteransCompletedNCT01516489Phase 1/2
- Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver MetastasesTerminatedNCT01508000Phase 2
- Increasing Colorectal Cancer Screening Uptake With a Patient NavigatorCompletedNCT01506687Phase 3
- An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)CompletedNCT01506167
- Time Schedules for Sending Invitations to Colonoscopy ScreeningCompletedNCT01505972Not applicable
- Integrated Molecular Profiling in Advanced Cancers TrialActive, not recruitingNCT01505400
- Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal CancerCompletedNCT01493713Phase 4
- A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid TumoursCompletedNCT01493336Phase 1
- R-21 Colorectal Cancer Screening (CRCS) Pilot TrialCompletedNCT01492049Not applicable
- Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal CancerCompletedNCT01490996Phase 1/2
- Urine Metabolomics and Colorectal Cancer ScreeningCompletedNCT01486745
- Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal CancerCompletedNCT01486251Not applicable
- Axitinib as Maintenance Treatment in Patients With Metastatic CRCTerminatedNCT01483638Phase 2
- Synbiotics and Gastrointestinal Function Related Quality of Life After Colectomy for CancerCompletedNCT01479907Not applicable
- Interventions to Improve Colon Cancer Screening in Poor Rural Iowa CountiesCompletedNCT01477814Not applicable
- A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal CancerCompletedNCT01472770Phase 2
- Surgical Resection Lowers Oxidative Stress Markers in Patients With Colorectal CancerCompletedNCT01470586Not applicable
- A Trial of JX-594 in Refractory Colorectal CarcinomaCompletedNCT01469611Phase 1
- Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6TerminatedNCT01468623Phase 4
- Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human SkinTerminatedNCT01466504
- Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and SafetyStatus unknownNCT01465451Phase 3
- Risk Factors for Colorectal Cancer in Patients With Inflammatory Bowel Disease Undergoing Surveillance: a Prospective Cohort StudyCompletedNCT01464151
- L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic MetastasesCompletedNCT01462513Phase 2
- Vaccination Against MSI Colorectal CancerCompletedNCT01461148Phase 1/2
- A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical PracticeCompletedNCT01460745
- Feasibility of Check-Cap's P1 Capsule System ScreeningTerminatedNCT01458925Not applicable
- A Longitudinal Investigation of Cognitive Function in Colorectal Cancer PatientsCompletedNCT01457287
- Chemotherapy With DNA Damaging Agents In Colorectal CancerCompletedNCT01456923Phase 1
- Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal CancerCompletedNCT01455831Phase 3
- S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer SurvivorsCompletedNCT01453452Not applicable
- Iscador Qu as Supportive Treatment in Colorectal Cancer (Union International Cancer Control, UICC Stages II-IV)Status unknownNCT01448655
- The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)Status unknownNCT01447199
- Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic MetastasesCompletedNCT01442935Phase 2
- Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With BevacizumabCompletedNCT01442649Phase 2
- Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community SettingCompletedNCT01440855Not applicable
- Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic MarkersTerminatedNCT01440127Phase 1
- First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal CancerCompletedNCT01437618
- TKM 080301 for Primary or Secondary Liver CancerCompletedNCT01437007Phase 1
- Evaluating Personalized Effect of an Individualized InterventionCompletedNCT01434264Not applicable
- Does Endoscope Position Detecting Unit Facilitate a Complete Colonoscopy ExaminationStatus unknownNCT01434199Phase 3
- Effect of Temperament, Anxiety and Depression on Immuninity in Colorectal Cancer Patients. Effetti Del Temperamento, Dell'Ansia e Della Depressione Sulla Sopravvivenza Globale e Sulla Risposta Immunitaria Del Paziente Affetto da Adenocarcinoma Colo-Rettale.CompletedNCT01433146
- Study of Prevalence of Colorectal Adenoma in 30- to 49-year-old Subjects With a Family History of Colorectal CancerStatus unknownNCT01428752
- Inflammatory Response After Colorectal Cancer SurgeryCompletedNCT01427647Not applicable
- The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal CancerStatus unknownNCT01426490Phase 2/3
- Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)CompletedNCT01420874Phase 1
- SKIP - A Double-blind Placebo-controlled Randomized Multicenter Trial of Skin Toxicity TreatmentTerminatedNCT01418742Phase 2
- FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal CancerCompletedNCT01418222Phase 2
- The Usefulness of I-scan in Screening ColonoscopyCompletedNCT01417611Not applicable
- 1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal CancerCompletedNCT01417494Phase 2
- S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib HydrochlorideCompletedNCT01416688
- Pilot Study of a Geriatric Intervention After Colorectal and Lung Cancer SurgeryCompletedNCT01416168Not applicable
- Tailored Web-Based Intervention for Cancer Patients and Family CaregiversCompletedNCT01415089Not applicable
- Randomized Trial With Dendritic Cells in Patients With Metastatic Colorectal CancerCompletedNCT01413295Phase 2
- PERfusion CT in the FOXFIRE Trial to Study Blood Flow to Liver MetastasesStatus unknownNCT01410760Early Phase 1
- Gemcitabine-UFTE Chemotherapy in Refractory Colorectal CancerCompletedNCT01409005Phase 2
- Association Between Hepatitis C Infection and Renal Cell CarcinomaCompletedNCT01405183
- A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal CancerCompletedNCT01399684Phase 2
- A Sustainable Approach to Increasing Cancer ScreeningCompletedNCT01395459Not applicable
- Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and AsthmaCompletedNCT01393340Phase 2
- Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal CancerCompletedNCT01387880Phase 2
- Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal CancerCompletedNCT01386242Phase 2
- Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type PatientsStatus unknownNCT01384994Phase 2
- Unsedated Colonoscopy for Colorectal Cancer Screening and SurveillanceCompletedNCT01383252Not applicable
- Does Acne Rash During Adolescence Predict Skin Reaction to CetuximabCompletedNCT01382407
- Pre-emptive Low-dose Doxycycline During Anti-EGFR TreatmentStatus unknownNCT01380262
- Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard ChemotherapyCompletedNCT01378143Phase 2
- Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal CancerTerminatedNCT01375816Phase 2
- Faith Moves Mountains: A Community Based Participatory Research (CBPR) Appalachian Wellness & Cancer Prevention ProgramCompletedNCT01373320Not applicable
- Population-Based Patient-Centric Care: Comprehensive Preventive Cancer Screening Using Health ITCompletedNCT01372527Not applicable
- Mutational Profiling in Colorectal Tumors to Determine Its Role in the Diagnosis, Prognostic Significance and Their Impact in Clinical ManagementStatus unknownNCT01371942
- Colonoscopy Screening Using a Novel Slim Colonoscope - a Randomized Controlled TrialCompletedNCT01370928Phase 3
- General Practitioners (GP) Involvement in Colorectal Cancer (CRC) ScreeningCompletedNCT01364454Early Phase 1
- Evaluation of VEGF Polymorphism as Predictive Factor in Metastatic Colorectal Cancer Treated With Folfiri Plus BevacizumabStatus unknownNCT01363739
- TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)CompletedNCT01362361Phase 2
- Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy PatientsCompletedNCT01361035Not applicable
- FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal CancerCompletedNCT01358812Phase 2
- Multimodal Prehabilitation for Colorectal SurgeryCompletedNCT01356264Phase 2
- A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsCompletedNCT01351103Phase 1
- S0820, Adenoma and Second Primary Prevention TrialActive, not recruitingNCT01349881Phase 3
- Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy FailureCompletedNCT01348412Phase 2
- Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal CarcinomaStatus unknownNCT01348256Phase 2
- Effect of Intravenous Lidocaine on the Tolerability of Early Oral Feeding After Laparoscopic Colorectal SurgeryCompletedNCT01346917Not applicable
- Efficacy and Safety of the Prophylactic Use of Doxycycline +/- Vitamin K CreamCompletedNCT01345526Phase 2
- Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI TrialCompletedNCT01344304Not applicable
- Fast-track Perioperative Program for Laparoscopic Colorectal SurgeryCompletedNCT01341366Phase 3
- Fecal Screening Assay for Taiwanese PopulationCompletedNCT01341197
- A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to CetuximabWithdrawnNCT01338558Phase 3
- Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting BeadsTerminatedNCT01336985Phase 1
- Curcumin BiomarkersCompletedNCT01333917Phase 1
- Specimens for Septin 9 PerformanceCompletedNCT01329718Early Phase 1
- FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI)CompletedNCT01328171Phase 2
- A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal CancerCompletedNCT01326000Phase 2